Ronald Peck
Nessuna posizione attualmente
Patrimonio netto: 439 935 $ in data 30/04/2024
Profilo
Ronald Peck ricopre la posizione di Chief Medical Officer di Arvinas, Inc. In passato il Dr. Peck ha occupato la posizione di Vice Presidente-Yervoy Global Development Lead presso Bristol Myers Squibb Co., Chief Medical Officer per Kolltan Pharmaceuticals, Inc., Senior Vice President-Clinical Research presso Tesaro, Inc. e Assistant Professor presso l'Università della Virginia. La dottoressa Peck si è laureata alla Georgetown University e ha conseguito il dottorato al Sidney Kimmel Medical College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ARVINAS, INC.
0.02% | 31/03/2024 | 13 922 ( 0.02% ) | 439 935 $ | 30/04/2024 |
Precedenti posizioni note di Ronald Peck
| Società | Posizione | Fine |
|---|---|---|
| ARVINAS, INC. | Direttore Tecnico/Scientifico/R&S | 18/03/2024 |
| TESARO INC | Direttore Tecnico/Scientifico/R&S | 01/07/2019 |
Kolltan Pharmaceuticals, Inc.
 Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Direttore Tecnico/Scientifico/R&S | 01/12/2016 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/05/2015 |
| University of Virginia | Corporate Officer/Principal | 01/02/2000 |
Formazione di Ronald Peck
| Georgetown University | Undergraduate Degree |
| Sidney Kimmel Medical College | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ARVINAS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Aziende private | 2 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Health Technology |
- Borsa valori
- Insiders
- Ronald Peck
